Oral mexiletine in high-risk patients after myocardial infarction

trans-2-Nonenal insect repellent, insecticide, and flavor compound in carrot roots, cell suspensions, and "hairy" root cultures.

Journal of chemical ecology·2013

pEmu: an improved promoter for gene expression in cereal cells.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013

A national scheme for public access defibrillation in England and Wales: early results.

Resuscitation·2008

Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial.

Heart (British Cardiac Society)·2006

A national programme for on-site defibrillation by lay people in selected high risk areas: initial results.

Heart (British Cardiac Society)·2005

Translation of clinical trials into clinical practice.

Journal of internal medicine·2004

Understanding peripheral arterial disease in the current era.

Lancet (London, England)·2026

Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment.

Lancet (London, England)·2026

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.

Lancet (London, England)·2026

Developing roadmaps for advancing practice, research, and policy in the arts and health.

Lancet (London, England)·2026

Precision prevention and early detection: framework for a new clinical cancer control pathway.

Lancet (London, England)·2026

Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.

Lancet (London, England)·2026

HER2-Targeted AIE Nanotheranostics Overcome SHR-A1811 Resistance via Immunogenic Pyroptosis and Tumor-Associated Macrophage Reprogramming in Breast Cancer.

Small (Weinheim an der Bergstrasse, Germany)·2026

Systemic administration of the PRMT5 inhibitor GSK3326595 does not induce overt cardiotoxicity in the murine heart.

Journal of molecular and cellular cardiology plus·2026

Promotion or suppression? Does internet use by the Chinese public affect physician trust?

Frontiers in public health·2026

The Phosphate-Specific Transport System Gene pstA1 Contributes to Rifampin Tolerance in Mycobacterium tuberculosis.

The Journal of infectious diseases·2026

Could thiamine supplementation delay the progression of retinal dystrophy in Rogers syndrome?

Ophthalmic genetics·2026

Treat-to-target: LLDAS, DORIS remission, and flare prevention strategies.

Rheumatology (Oxford, England)·2026

Related Experiment Videos

Oral mexiletine in high-risk patients after myocardial infarction

Related Concept Videos

trans-2-Nonenal insect repellent, insecticide, and flavor compound in carrot roots, cell suspensions, and "hairy" root cultures.

pEmu: an improved promoter for gene expression in cereal cells.

A national scheme for public access defibrillation in England and Wales: early results.

Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial.

A national programme for on-site defibrillation by lay people in selected high risk areas: initial results.

Translation of clinical trials into clinical practice.

Understanding peripheral arterial disease in the current era.

Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment.

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.

Developing roadmaps for advancing practice, research, and policy in the arts and health.

Precision prevention and early detection: framework for a new clinical cancer control pathway.

Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.

HER2-Targeted AIE Nanotheranostics Overcome SHR-A1811 Resistance via Immunogenic Pyroptosis and Tumor-Associated Macrophage Reprogramming in Breast Cancer.

Systemic administration of the PRMT5 inhibitor GSK3326595 does not induce overt cardiotoxicity in the murine heart.

Promotion or suppression? Does internet use by the Chinese public affect physician trust?

The Phosphate-Specific Transport System Gene pstA1 Contributes to Rifampin Tolerance in Mycobacterium tuberculosis.

Could thiamine supplementation delay the progression of retinal dystrophy in Rogers syndrome?

Treat-to-target: LLDAS, DORIS remission, and flare prevention strategies.

Related Experiment Videos

Oral mexiletine in high-risk patients after myocardial infarction

Related Concept Videos

Related Articles